A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2001
11/29/2001	WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001089570A2 Combination of growth hormone secretagogues and antidepressants
11/29/2001	WO2001089523A1 New pharmaceutical composition and the process for its preparation
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof
11/29/2001	WO2001089516A1 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
11/29/2001	WO2001089515A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	WO2001089502A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	WO2001089479A2 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001035902A9 Stabilized thyroxine compounds
11/29/2001	WO2000041548A3 Methods for glucagon suppression
11/29/2001	US20010047030 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
11/29/2001	US20010047008 Allosteric adenosine receptor modulators
11/29/2001	US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001	US20010046524 Administering to the patient a formulation comprising an extract of Eucommia ulmoides (plant extract) or an extract of botanical equivalent of Eucommia extract or acomponent to modulalte steroid-mediated physiological condition
11/29/2001	US20010046481 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/29/2001	DE10024939A1 Neue Diphenylmethanderivate für Arzneimittel New diphenylmethane derivatives for pharmaceuticals
11/29/2001	DE10024451A1 Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung Pharmaceutical form of administration for peptides, process for their preparation and use
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2409929A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001	CA2407028A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1157996A1 New solid forms of mesoprogestin 11beta-(4E-(hydroxyiminomethyl)-phenyl)-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1156808A2 Enhancement of return to independent living status with a growth hormone secretagogue
11/28/2001	EP1156787A1 Oxadiazole compounds and compositions for delivering active agents
11/28/2001	EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs
11/28/2001	EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
11/28/2001	CN1324257A Vaporizing device for administering sterile medication
11/28/2001	CN1324241A Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
11/27/2001	US6323242 Treatment of disorders secondary to organic impairments
11/27/2001	US6323225 Pharmaceutical composition
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001087886A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087810A1 Methods for the production of d-chiro-inositol and the use of d-chiro-inositol obtained therefrom
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087316A2 Composition and method for increasing testosterone levels
11/22/2001	WO2001087287A2 Use of pyrazole derivatives for treating infertility
11/22/2001	WO2001087286A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
11/22/2001	WO2001087284A2 Aldosterone antagonist composition for release during aldosterone acrophase
11/22/2001	WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001	WO2001087265A2 Pharmaceutical form of administration for peptides, methods for its production and use
11/22/2001	WO2001087038A2 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
11/22/2001	WO2001038355A3 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
11/22/2001	WO2001034126A3 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010044434 Treating timidity and enhancing libido in postmenopausal women, or treating male sexual dysfunction by administering to a patient in need thereof an effective amount of an estrogen agonist/antagonist
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2409699A1 Novel polymorph v of torasemide
11/22/2001	CA2409437A1 Aldosterone antagonist composition for release during aldosterone acrophase
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2405507A1 Use of pyrazole derivatives for treating infertility
11/21/2001	EP1155014A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154788A1 Inhibitors of separin, method for identifying them and uses
11/21/2001	EP0918774B1 Androgen receptor modulator compounds and methods
11/21/2001	EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001	EP0659179B1 Benzo-fused lactams promote release of growth hormone
11/21/2001	CN1323348A Delivery system for porcine somatotropin
11/21/2001	CN1323346A TPL-2/COT kinase and methods of use
11/21/2001	CN1323314A Inhibitors of caspases
11/21/2001	CN1323213A Blood-brain barrier therapeutics
11/21/2001	CN1323198A Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
11/21/2001	CN1323186A Two chamber cartridge for atomizers
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1075069C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes
11/20/2001	US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319900 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319506 Method for treating hypercalcemia
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085783A2 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof
11/15/2001	WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085698A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	WO2001085197A1 Method for curing diffusive masthopaty
11/15/2001	WO2001085175A2 Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with ns398 or pdtc

1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 290